Centro Integral en Reumatología S.A. de C.V. - CIRSA Reumatología

Centro de Investigación con más de 20 años de experiencia en el desarrollo de estudios clínicos con enfoque en el área de Reumatología, también ofrecemos atención médica especializada a pacientes con enfermedades de tipo reumatológico.
logoCentro Integral en Reumatología S.A. de C.V. - CIRSA Reumatología
Av. de la Paz 1919, Col Americana, Americana, 44150 Guadalajara, Jal., Mexico
Select an option

Specializations

Reumatología
Cardiología

Our team

Authorities
Farmacista y Subdirector null null
Investigador Principal y Director GeneralHilario Avila Armengol
Medical staff
Coordinadora de estudio (Coordinadora Clínica)Teresita Ruelas Lambaren
Enfermera de EstudioNancy López Ramírez
Investigadora Principal - SubinvestigadoraAlejandra Ramos Hernández
SubinvestigadorHugo Antonio Ascencio Hernández
Investigadora Principal - SubinvestigadoraLiliana Flores González
Legal and Administrative staff
Coordinadora de Estudio (Área Regulatoria)Blanca Estela Ornelas López
Coordinadora de Estudio (Captura eCRF)Lorena Carnahan Barragan

Open studies

Lupus
Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis - IRIS - AstraZenecaSee more
Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus Erythematosus - LUMUS - Alumis IncSee more
Efficacy And Safety Of MK-6194 In Adult Participants With Systemic Lupus Erythematosus (MK-6194-006) - Merck Sharp & Dohme LLCSee more
Rare diseases
A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease - Moonscape - Genentech, Inc.See more
Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY) - DAISY - AstraZenecaSee more
A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity - Oasiz - Horizon Therapeutics Ireland DACSee more
Pulmonary fibrosis
A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease - Moonscape - Genentech, Inc.See more
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy